Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
The Prayagraj lab is designed to handle both routine and specialised testing
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
We are building the bridge between complex molecular data and everyday clinical decisions
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Subscribe To Our Newsletter & Stay Updated